Matrix proteases, green tea, and St. John's wort: Biomedical research catches up with folk medicine

Clinica Chimica Acta

Volumn 381, Issue 1, 2007, Pages 69-77

  Dell'Aica, Isabella ^a   Caniato, Rosy ^a   Biggin, Susan ^b   Garbisa, Spiridione ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Institute of Physics   (United Kingdom)

Author keywords

EGCG; Green tea; Hyperforin; Hypericum sp; Matrix proteases

Indexed keywords

ANTIDEPRESSANT AGENT; CATHEPSIN G; DEXAMETHASONE; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; HYPERFORIN; HYPERICUM EXTRACT; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MIFEPRISTONE; PHENOBARBITAL; PROTEINASE; RIFAMPICIN; TAMOXIFEN; THROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANXIETY; CANCER INVASION; CELL MIGRATION; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; EXTRAVASATION; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; INFLAMMATION; LUNG FIBROSIS; MEDICAL RESEARCH; METASTASIS; NONHUMAN; PHOTOSENSITIVITY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINASE INHIBITION; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; TEA; TRADITIONAL MEDICINE; XEROSTOMIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BICYCLO COMPOUNDS; CATECHIN; HUMANS; HYPERICUM; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; PHLOROGLUCINOL; PULMONARY FIBROSIS; TEA; TERPENES;

HYPERICUM;

EID: 34248173053     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.02.022     Document Type: Review

References (28)

1. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., and Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284 (1980) 67-68
2. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (2002) 2387-2392
3. Kalebic T., Garbisa S., Glaser B., and Liotta L.A. Degradation of basement membrane collagens by migrating endothelial cells. Science 221 (1983) 281-283
4. Garbisa S., Ballin M., Daga-Gordini D., et al. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem 261 (1986) 2369-2375
5. Cao Y., and Cao R. Angiogenesis inhibited by drinking tea. Nature 398 (1999) 381
6. Garbisa S., Biggin S., Cavallarin N., Sartor L., Benelli R., and Albini A. Tumor invasion: molecular shears blunted by green tea. Nature Med 5 (1999) 1216
7. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42 (2002) 25-54
8. Jian L., Xie P.L., Lee A.H., and Binns C.W. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 108 (2004) 130-135
9. Garbisa S., Sartor L., Biggin S., Salvato B., Benelli R., and Albini A. Tumor gelatinases and invasion inhibited by green tea flavanol epigallocatechin-3-gallate. Cancer 91 (2001) 822-832
10. Sartor L., Pezzato E., and Garbisa S. (-)Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phytofactor in hindering inflammation, emphysema, and invasion. J Leukoc Biol 71 (2002) 73-79
11. Donà M., Dell'Aica I., Calabrese F., et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis and pulmonary fibrosis. J Immunol 170 (2003) 4335-4341
12. Schempp C.M., Winghofer B., Ludtke R., Simon-Haarhaus B., Schöpf E., and Simon J.C. Topical application of St. John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Dermatol 142 (2000) 979-984
13. Schempp C.M., Kirkin V., Simon-Haarhaus B., et al. Inhibition of tumor cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 21 (2002) 1242-1250
14. Schempp C.M., Pelz K., Wittmer A., Schöpf E., and Simon J.C. Antibacterial activity of hyperforin from Saint John's wort, against multiresistant Staphylococcus aureus and Gram-positive bacteria. Lancet 353 (1999) 2129
15. Barnes J., Anderson L.A., and Phillipson J.D. St. John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53 (2001) 583-600
16. Donà M., Dell'Aica I., Pezzato E., et al. Hyperforin inhibits cancer invasion and metastasis. Cancer Res 64 (2004) 6225-6232
17. Biber A., Fisher H., Romer A., and Chetterjee S.S. Oral bioavailability of hyperforin from Hypericum extracts in rats and human volunteers. Pharmacopsychiatry 31 (1998) 36-43
18. Achilles K., and Bednarski P.J. Quantification of elastase-like activity in 13 human cancer cell lines and in an immortalized human epithelial cell line by RT-HPLC. Biol Chem 384 5 (2003) 817-824
19. Tanaka E., Yamashita J., Hayashi N., Kato S., and Ogawa M. A pulmonary metastatic model of human non-small cell lung carcinoma cells that produce a neutrophil elastase-like molecule in severe combined immunodeficiency mice. Chest 123 4 (2003) 1248-1253
20. Nelson W.G., De Marzo A.M., and Isaacs W.B. Prostate cancer. N Engl J Med 349 (2003) 366-381
21. Foekenss J.A., Ries C., Look M.P., Gippner-Steppert C., Klijn J.G.M., and Jochum M. Elevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease. Br J Cancer 88 (2003) 1084-1090
22. Dell'Aica I., Calabrese F., Sartor L., et al. Hyperforin blocks neutrophil activation of MMP-9 and motility, and restrains inflammation-triggered angiogenesis and pulmonary fibrosis. J Pharmacol Exp Ther 321 2 (2007) 000 (Now scheduled for publication; no page numbers yet)
23. Ernst E., Rand J.I., Barnes J., and Stevinson C. Adverse effects profile of the herbal antidepressant St John's wort (Hypericum perforatum L.). Eur J Clin Pharmacol 54 (1998) 589-594
24. Markowitz J.S., Donovan J.L., DeVane C.L., et al. Effect of St. John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. J Am Med Assoc 290 (2003) 1500-1504
25. Durr D., Stieger B., Kullak-Ublick G.A., et al. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68 (2000) 598-604
26. Madabushi R., Frank B., Drewelow B., Derendorf H., and Butterweck V. Hyperforin in St. John's wort drug interactions. Eur J Clin Pharmacol 62 3 (2006) 225-233
27. De Shan M., Hu L.H., and Chen Z.L. Three new hyperforin analogues from Hypericum perforatum. J Nat Prod 64 (2001) 127-130
28. Verotta L., Appendino G., Belloro E., et al. Synthesis and biological evaluation of hyperforin analogues. Part I. Modification of the enolized cyclohexanedione moiety. J Nat Prod 65 (2002) 433-438